These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 22684217

  • 1. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
    Schildhaus HU, Heukamp LC, Merkelbach-Bruse S, Riesner K, Schmitz K, Binot E, Paggen E, Albus K, Schulte W, Ko YD, Schlesinger A, Ansén S, Engel-Riedel W, Brockmann M, Serke M, Gerigk U, Huss S, Göke F, Perner S, Hekmat K, Frank KF, Reiser M, Schnell R, Bos M, Mattonet C, Sos M, Stoelben E, Wolf J, Zander T, Buettner R.
    Mod Pathol; 2012 Nov; 25(11):1473-80. PubMed ID: 22684217
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH.
    Russell PA, Yu Y, Young RJ, Conron M, Wainer Z, Alam N, Solomon B, Wright GM.
    Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.
    Clauditz TS, Böttcher A, Hanken H, Borgmann K, Sauter G, Wilczak W, Grob T, Münscher A.
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097
    [Abstract] [Full Text] [Related]

  • 4. Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.
    Sousa V, Reis D, Silva M, Alarcão AM, Ladeirinha AF, d'Aguiar MJ, Ferreira T, Caramujo-Balseiro S, Carvalho L.
    Virchows Arch; 2016 Aug; 469(2):173-82. PubMed ID: 27194548
    [Abstract] [Full Text] [Related]

  • 5. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
    Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deimling A, Streubel B, Birner P.
    Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
    [Abstract] [Full Text] [Related]

  • 6. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ.
    J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.
    Kwon D, Yun JY, Keam B, Kim YT, Jeon YK.
    World J Gastroenterol; 2016 Nov 28; 22(44):9803-9812. PubMed ID: 27956804
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC.
    J Clin Oncol; 2013 Feb 20; 31(6):731-7. PubMed ID: 23182986
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
    Kim HS, Lee SE, Bae YS, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Jung DH, Shin SK, Lee SK, Lee YC, Kim HR, Moon YW, Kim JH, Shim YM, Jewell SS, Kim H, Choi YL, Cho BC.
    Oncotarget; 2015 Feb 10; 6(4):2562-72. PubMed ID: 25537505
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
    Cihoric N, Savic S, Schneider S, Ackermann I, Bichsel-Naef M, Schmid RA, Lardinois D, Gugger M, Bubendorf L, Zlobec I, Tapia C.
    Br J Cancer; 2014 Jun 10; 110(12):2914-22. PubMed ID: 24853178
    [Abstract] [Full Text] [Related]

  • 15. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H, Ebi H, Kitai H, Nanjo S, Kita K, Huynh TG, Ooi A, Faber AC, Mino-Kenudson M, Yano S.
    Oncogene; 2016 Jul 07; 35(27):3587-97. PubMed ID: 26549034
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.
    Schultheis AM, Bos M, Schmitz K, Wilsberg L, Binot E, Wolf J, Büttner R, Schildhaus HU.
    Mod Pathol; 2014 Feb 07; 27(2):214-21. PubMed ID: 23887299
    [Abstract] [Full Text] [Related]

  • 17. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
    Flockerzi FA, Roggia C, Langer F, Holleczek B, Bohle RM.
    Virchows Arch; 2018 May 07; 472(5):759-769. PubMed ID: 29270870
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
    Schröck A, Göke F, Wagner P, Bode M, Franzen A, Huss S, Agaimy A, Ihrler S, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S.
    Head Neck; 2014 Sep 07; 36(9):1253-7. PubMed ID: 23913758
    [Abstract] [Full Text] [Related]

  • 19. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
    Seo AN, Jin Y, Lee HJ, Sun PL, Kim H, Jheon S, Kim K, Lee CT, Chung JH.
    Virchows Arch; 2014 Nov 07; 465(5):547-58. PubMed ID: 25086725
    [Abstract] [Full Text] [Related]

  • 20. FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.
    Schildhaus HU, Nogova L, Wolf J, Buettner R.
    Transl Lung Cancer Res; 2013 Apr 07; 2(2):92-100. PubMed ID: 25806220
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.